trending Market Intelligence /marketintelligence/en/news-insights/trending/3hsrpvhrvvghxw4xja6hvq2 content esgSubNav
In This List

Anavex Life Sciences appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Anavex Life Sciences appoints board member

Anavex Life Sciences Corp. appointed Claus van der Velden to its board of directors.

Van der Velden is Ströer SE & Co. KGaA's corporate head of management accounting, internal audit and risk management.

Anavex is a New York-based biopharmaceutical company developing treatments for neurological diseases.